Therapeutics Acquisition
General Information | |
Business: |
While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare industry, with an emphasis on the biotechnology sector where our management has extensive investment experience. |
Industry: | BLANK CHECKS |
Employees: | 0 |
Founded: | 2020 |
Contact Information | |
Address | 200 Berkeley Street 18th Floor, Boston, MA 02116, US |
Phone Number | (617) 778.2500 |
Web Address | |
View Prospectus: | Therapeutics Acquisition |
Financial Information | |
Market Cap | $151.8mil |
Revenues | $0 mil (last 12 months) |
Net Income | $0 mil (last 12 months) |
IPO Profile | |
Symbol | TXAC |
Exchange | NASDAQ |
Shares (millions): | 11.8 |
Price range | $10.00 - $10.00 |
Est. $ Volume | $118.0 mil |
Manager / Joint Managers | Jefferies |
CO-Managers | - |
Expected To Trade: | 7/8/2020 |
Status: | Priced |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |